Stereotaxis (STXS) vs Vivani Medical (VANI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Vivani Medical (VANI) has outperformed Stereotaxis (STXS) over the past year, losing 11.3% versus a loss of 67.1%. Over five years, STXS leads with a -81.3% price change compared with -85.7% for VANI. Vivani Medical is the larger company by market cap ($112.8 million vs $111.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | STXS | VANI |
|---|---|---|
| Share price | $1.11 | $1.25 |
| Market cap | $111.22M | $112.75M |
| 1-day change | 0.00% | +1.63% |
| YTD return | -51.74% | +1.63% |
| 1-year return | -67.06% | -11.35% |
| 5-year return | -81.28% | -85.73% |
| EPS (TTM) | $-0.24 | $-0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.20 | $1.92 |
| 52-week low | $1.09 | $0.923 |
| Distance from 52-week high | -65.31% | -34.90% |
| Analyst consensus | none | none |
| Avg. price target upside | +170.27% | +206.40% |
| Average volume | 812.23K | 228.48K |
| Shares outstanding | 100.20M | 90.20M |
| Employees | 131 | 42 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VANI has outperformed STXS by 55.7 percentage points over the past year.
About Stereotaxis
STXS stock →Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 131 employees
About Vivani Medical
VANI stock →Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 42 employees
STXS vs VANI FAQ
Which is bigger, Stereotaxis or Vivani Medical?
Vivani Medical (VANI) is larger, with a market capitalization of $112.75M compared with $111.22M for Stereotaxis (STXS).
Which stock has performed better over the past year, STXS or VANI?
VANI returned -11.35% over the past 12 months, compared with -67.06% for STXS (price return, excluding dividends). Past performance does not predict future results.
Are Stereotaxis and Vivani Medical in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.